Agilent Technologies (NYSE:A – Get Rating) issued an update on its FY22 earnings guidance on Tuesday morning. The company provided EPS guidance of $4.86-4.93 for the period, compared to the consensus EPS estimate of $4.86. The company issued revenue guidance of $6.67-6.73 billion, compared to the consensus revenue estimate of $6.73 billion.Agilent Technologies also updated its FY 2022 guidance to $4.86-$4.93 EPS.
Several analysts have commented on the stock. Stifel Nicolaus decreased their target price on shares of Agilent Technologies from $169.00 to $145.00 and set a hold rating for the company in a research report on Wednesday, February 23rd. Cowen reduced their price target on shares of Agilent Technologies from $187.00 to $178.00 and set an outperform rating for the company in a report on Wednesday, February 23rd. Citigroup reduced their price target on shares of Agilent Technologies from $190.00 to $175.00 and set a buy rating for the company in a report on Wednesday, February 23rd. Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $160.00 to $130.00 and set an equal weight rating for the company in a research report on Monday, April 25th. Finally, StockNews.com upgraded shares of Agilent Technologies from a buy rating to a strong-buy rating in a research report on Thursday, May 19th. Three analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of Buy and an average target price of $163.08.
NYSE:A traded down $1.57 on Tuesday, hitting $124.41. 2,149,569 shares of the company’s stock were exchanged, compared to its average volume of 2,088,196. The firm has a 50-day moving average price of $127.21 and a 200-day moving average price of $139.27. Agilent Technologies has a 52 week low of $112.64 and a 52 week high of $179.57. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.19 and a quick ratio of 1.64. The company has a market cap of $37.37 billion, a P/E ratio of 31.58, a price-to-earnings-growth ratio of 2.80 and a beta of 1.06.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 27th. Shareholders of record on Tuesday, July 5th will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Friday, July 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 21.32%.
In related news, SVP Michael Tang sold 1,210 shares of the stock in a transaction on Friday, March 18th. The stock was sold at an average price of $136.21, for a total value of $164,814.10. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Synovus Financial Corp increased its stake in shares of Agilent Technologies by 2.3% in the 1st quarter. Synovus Financial Corp now owns 6,751 shares of the medical research company’s stock valued at $895,000 after purchasing an additional 153 shares during the last quarter. Horizon Investments LLC lifted its stake in Agilent Technologies by 7.3% in the 4th quarter. Horizon Investments LLC now owns 2,394 shares of the medical research company’s stock valued at $382,000 after purchasing an additional 162 shares during the last quarter. EverSource Wealth Advisors LLC acquired a new stake in Agilent Technologies in the fourth quarter valued at approximately $31,000. Brinker Capital Investments LLC grew its stake in shares of Agilent Technologies by 2.2% during the first quarter. Brinker Capital Investments LLC now owns 10,216 shares of the medical research company’s stock worth $1,352,000 after buying an additional 218 shares during the last quarter. Finally, Geller Advisors LLC increased its holdings in shares of Agilent Technologies by 18.5% during the first quarter. Geller Advisors LLC now owns 1,602 shares of the medical research company’s stock worth $212,000 after buying an additional 250 shares in the last quarter.
Agilent Technologies Company Profile (Get Rating)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Zoom Video Communications Is Primed To Launch Higher
- Veeva Systems: Increasing NDR and Other Wins
- Institutions Buy The Dip In Petco Health and Wellness Company
- Fundamental Strength Makes Williams-Sonoma One for Your Recovery Watchlist
- Autozone Edges Past Advanced Auto Parts In Q1 2022
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.